{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:31:33Z","timestamp":1793413893621,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100032767","name":"Sichuan Medical Association","doi-asserted-by":"publisher","award":["Q2024030"],"award-info":[{"award-number":["Q2024030"]}],"id":[{"id":"10.13039\/100032767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017545","name":"Hunan Provincial People's Hospital","doi-asserted-by":"publisher","award":["24QNPY005"],"award-info":[{"award-number":["24QNPY005"]}],"id":[{"id":"10.13039\/501100017545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304558"],"award-info":[{"award-number":["82304558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbadis.2026.168315","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:47:11Z","timestamp":1781048831000},"page":"168315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["SPDEF promotes clear cell renal cell carcinoma progression by transcriptionally activating ELOVL2-mediated lipid metabolic reprogramming"],"prefix":"10.1016","volume":"1872","author":[{"given":"Pu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168315_bb0005","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168315_bb0010","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1158\/2159-8290.CD-21-0211","article-title":"Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma","volume":"11","author":"Riscal","year":"2021","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168315_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168315_bb0020","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01965-8","article-title":"HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism","volume":"8","author":"Du","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168315_bb0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s42255-021-00367-x","article-title":"Glycogen metabolism is dispensable for tumour progression in clear cell renal cell carcinoma","volume":"3","author":"Xie","year":"2021","journal-title":"Nat. Metab."},{"issue":"19","key":"10.1016\/j.bbadis.2026.168315_bb0035","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.7150\/jca.30989","article-title":"Elevated CD36 expression correlates with increased visceral adipose tissue and predicts poor prognosis in ccRCC patients","volume":"10","author":"Xu","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","article-title":"Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets","volume":"20","author":"Tan","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbadis.2026.168315_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5702026","article-title":"High membranous expression of fatty acid transport protein 4 is associated with tumorigenesis and tumor progression in clear cell renal cell carcinoma","volume":"2019","author":"Kim","year":"2019","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188559","article-title":"Metabolic reprogramming in renal cancer: events of a metabolic disease","volume":"1876","author":"Chakraborty","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168315_bb0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3724\/abbs.2021023","article-title":"Overexpression CPT1A reduces lipid accumulation via PPAR\u03b1\/CD36 axis to suppress the cell proliferation in ccRCC","volume":"54","author":"Yang","year":"2022","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"13","key":"10.1016\/j.bbadis.2026.168315_bb0060","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1158\/0008-5472.CAN-23-2926","article-title":"GPR1 and CMKLR1 control lipid metabolism to support the development of clear cell renal cell carcinoma","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.bbadis.2026.168315_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214360","article-title":"Renal cell carcinoma as a metabolic disease: an update on main pathways, potential biomarkers, and therapeutic targets","volume":"23","author":"di Meo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168315_bb0070","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/0008-5472.CAN-03-3645","article-title":"Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity","volume":"64","author":"Kridel","year":"2004","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168315_bb0075","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1158\/1078-0432.CCR-12-3249","article-title":"Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma","volume":"19","author":"von Roemeling","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168315_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153227","article-title":"Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma","volume":"216","author":"Yuan","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168315_bb0085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmet.2018.07.020","article-title":"Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in vivo","volume":"28","author":"Courtney","year":"2018","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbcan.2018.06.003","article-title":"Genetic and metabolic hallmarks of clear cell renal cell carcinoma","volume":"1870","author":"Sanchez","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bbadis.2026.168315_bb0095","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41419-023-06098-z","article-title":"SPDEF enhances cancer stem cell-like properties and tumorigenesis through directly promoting GALNT7 transcription in luminal breast cancer","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168315_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113389","article-title":"HIF-2\u03b1-induced upregulation of CD36 promotes the development of ccRCC","volume":"421","author":"Liao","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2026.168315_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2022.105269","article-title":"Fatty acid transport proteins (FATPs) in cancer","volume":"250","author":"Acharya","year":"2023","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbadis.2026.168315_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.32948\/auo.2023.12.30","article-title":"Lipid metabolism pathway and renal tumor therapy","author":"Wang","year":"2023","journal-title":"Ann. Urol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168315_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.594705","article-title":"Upregulation of fatty acid transporters is associated with tumor progression in non-muscle-invasive bladder cancer","volume":"27","author":"Jeong","year":"2021","journal-title":"Pathol. Oncol. Res."},{"issue":"7456","key":"10.1016\/j.bbadis.2026.168315_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168315_bb0130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrneph.2017.59","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma","volume":"13","author":"Wettersten","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40170-022-00290-z","article-title":"ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma","volume":"10","author":"Klasson","year":"2022","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbadis.2026.168315_bb0140","article-title":"MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression","author":"Wang","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168315_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102043","article-title":"ACAT1 suppresses clear cell renal cell carcinoma progression by AMPK mediated fatty acid metabolism","volume":"47","author":"Zheng","year":"2024","journal-title":"Transl. Oncol."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168315_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11090608","article-title":"Renal lipid metabolism abnormalities in obesity and clear cell renal cell carcinoma","volume":"11","author":"Bobulescu","year":"2021","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.bbadis.2026.168315_bb0155","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/cas.15454","article-title":"ELOVL5-mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma","volume":"113","author":"Nitta","year":"2022","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clgc.2022.11.011","article-title":"Prognostic role of long-chain acyl-coenzyme a synthetase family genes in patients with clear cell renal cell carcinoma: a comprehensive bioinformatics analysis confirmed with external validation cohorts","volume":"21","author":"Temiz","year":"2023","journal-title":"Clin. Genitourin. Cancer"},{"issue":"18","key":"10.1016\/j.bbadis.2026.168315_bb0165","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1111\/febs.16446","article-title":"The atypical sphingosine 1-phosphate variant, d16:1 S1P, mediates CTGF induction via S1P2 activation in renal cell carcinoma","volume":"289","author":"Glueck","year":"2022","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168315_bb0170","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","article-title":"Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression","volume":"56","author":"Hu","year":"2024","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168315_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043272","article-title":"Lipids as targets for renal cell carcinoma therapy","volume":"24","author":"Stepanovska Tanturovska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168315_bb0180","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1074\/jbc.275.2.1216","article-title":"PDEF, a novel prostate epithelium-specific ETS transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression","volume":"275","author":"Oettgen","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168315_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004656","article-title":"SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene","volume":"10","author":"Cheng","year":"2014","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168315_bb0190","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2013.01.043","article-title":"SPDEF functions as a colorectal tumor suppressor by inhibiting \u03b2-catenin activity","volume":"144","author":"Noah","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bbadis.2026.168315_bb0195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ccr.2013.04.026","article-title":"PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells","volume":"23","author":"Buchwalter","year":"2013","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.bbadis.2026.168315_bb0200","doi-asserted-by":"crossref","first-page":"11572","DOI":"10.1158\/0008-5472.CAN-05-1196","article-title":"Novel role for PDEF in epithelial cell migration and invasion","volume":"65","author":"Gunawardane","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168315_bb0205","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.2147\/CMAR.S243748","article-title":"Double agent: SPDEF gene with both oncogenic and tumor-suppressor functions in breast cancer","volume":"12","author":"Ye","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2011.06.011","article-title":"Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor","volume":"310","author":"Steffan","year":"2011","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168315_bb0215","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41420-025-02479-9","article-title":"The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbadis.2026.168315_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.14820","article-title":"Lipid droplets provide metabolic flexibility for cancer progression","author":"Safi","year":"2024","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168315_bb0225","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1158\/0008-5472.CAN-20-2511","article-title":"ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer","volume":"81","author":"Centenera","year":"2021","journal-title":"Cancer Res."},{"issue":"492","key":"10.1016\/j.bbadis.2026.168315_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam6826","article-title":"Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer","volume":"10","author":"Chen","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbadis.2026.168315_bb0235","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2023-329839","article-title":"A mucus production programme promotes classical pancreatic ductal adenocarcinoma","author":"Tonelli","year":"2024","journal-title":"Gut"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392600178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392600178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:32:04Z","timestamp":1785911524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392600178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S092544392600178X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168315","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SPDEF promotes clear cell renal cell carcinoma progression by transcriptionally activating ELOVL2-mediated lipid metabolic reprogramming","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"168315"}}